From the American Heart Association
How does inflammation relate to heart disease and stroke risk?
“Inflammation” is the process by which the body responds to injury or an infection. Laboratory evidence and findings from clinical and population studies suggest that inflammation is important in atherosclerosis (ath”er-o-skleh-RO’sis). This is the process in which fatty deposits build up in the inner lining of arteries.
C-reactive protein (CRP) is one of the acute phase proteins that increase during systemic inflammation. It’s been suggested that testing CRP levels in the blood may be an additional way to assess cardiovascular disease risk. A more sensitive CRP test, called a highly sensitive C-reactive protein (hs-CRP) assay, is available to determine heart disease risk.
The American Heart Association and the Centers for Disease Control and Prevention published a joint scientific statement in 2003 on the use of inflammatory markers in clinical and public health practice. This statement was developed after systematically reviewing the evidence of association between inflammatory markers (mainly CRP) and coronary heart disease and stroke. Read More
